Sonographic risk stratification of FDG‐avid thyroid nodules using the Thyroid Imaging Reporting and Data System
Journal of Medical Imaging and Radiation Oncology · 2024
DOI: 10.1111/1754-9485.13712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2024. Verfasst von Tianchi Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging, Monash Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Thyroid Nodule, Fluorodeoxyglucose F18, Sensitivity and Specificity, Radiopharmaceuticals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
The increasing usage of positron emission tomography/computed tomography (PET/CT) for detection and monitoring of malignancy has led to an increase in incidental detection of thyroid nodules. Nodules that demonstrate increased avidity for 2‐[18F]‐fluoro‐2‐deoxy‐ d ‐glucose (FDG) have been shown to carry a high incidence of malignancy and warrant further investigation. At present, there has been limited research on the risk stratification of FDG‐avid thyroid incidentalomas. Thus, this study aims to evaluate the efficacy of the ACR TIRADS classification in the risk stratification of such nodules.
Methods
Data were collected retrospectively for FDG‐avid thyroid incidentalomas over a 10‐year period. Nodules were characterised using the TIRADS classification and, subsequently, underwent fine‐needle aspirate cytology. Cytological findings were classified using the Bethesda reporting system. Non‐diagnostic samples (Bethesda class I) were excluded. The remaining samples were divided into two groups: benign (Bethesda class II) or suspicious for malignancy/malignant (Bethesda class III or above).
Results
Thirty‐six percent of low‐risk nodules and 45% of high‐risk nodules were malignant, respectively ( P = 0.516). The sensitivity and specificity of TIRADS for detection of malignant nodules were 56% and 54%, respectively. There were no malignant TIRADS 1 or 2 nodules. The absence of any suspicious sonographic features had a 1.0 negative predictive value.
Conclusions
FDG‐avid nodules classified as TIRADS 1 or 2 or have no suspicious ultrasound features have a 0% incidence of malignancy and thus may not require further assessment with fine‐needle aspirate cytology (FNA) when detected incidentally. FDG‐avid nodules that are TIRADS 3 or above should undergo FNA regardless of size due to the high risk of malignancy and poor sensitivity of the TIRADS classification system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Imaging, Monash Health, Melbourne, Victoria, Australia.
ORCID-Profile: Tianchi Ren
Zitieren
APA
Ren, T., Lavender, I., Coombs, P., & Nandurkar, D. (2024). Sonographic risk stratification of FDG‐avid thyroid nodules using the Thyroid Imaging Reporting and Data System. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13712
Vancouver
Ren T, Lavender I, Coombs P, Nandurkar D. Sonographic risk stratification of FDG‐avid thyroid nodules using the Thyroid Imaging Reporting and Data System. Journal of Medical Imaging and Radiation Oncology. 2024. doi:10.1111/1754-9485.13712
BibTeX
@article{Ren2024,
author = {Ren, Tianchi and Lavender, Ilona and Coombs, Peter and Nandurkar, Dee},
title = {Sonographic risk stratification of FDG‐avid thyroid nodules using the Thyroid Imaging Reporting and Data System},
journal = {Journal of Medical Imaging and Radiation Oncology},
year = {2024},
doi = {10.1111/1754-9485.13712}
}
EUVIMED